Old Web
English
Sign In
Acemap
>
authorDetail
>
Ramesh Palaparthy
Ramesh Palaparthy
Pfizer
Biosimilar
Medicine
Infliximab
Internal medicine
Immunology
3
Papers
47
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A randomized controlled trial comparing PF-06438179/GP1111 (an infliximab biosimilar) and infliximab reference product for treatment of moderate to severe active rheumatoid arthritis despite methotrexate therapy
2018
Arthritis Research & Therapy
Stanley B. Cohen
Rieke Alten
Hideto Kameda
Tomas Hala
Sebastião Cezar Radominski
M.I. Rehman
Ramesh Palaparthy
Karl Schumacher
Susanne Schmitt
Steven Y. Hua
Claudia Ianos
K. Lea Sewell
Show All
Source
Cite
Save
Citations (32)
P554 Incidence and impact of immunogenicity in a randomised, double-blind phase III study comparing a proposed infliximab biosimilar (PF-06438179/GP1111) with reference infliximab
2018
Journal of Crohns & Colitis
Ramesh Palaparthy
S Schmitt
M.I. Rehman
C.H. Cai
K Wang
O. von Richter
Show All
Source
Cite
Save
Citations (1)
1